N@N

Cypress Bioscience, Inc.: Cypress Bioscience, Inc. to Present at RBC Capital Markets Healthcare Conference

^{Published on 2008-12-08 05:01:28 - Market Wire}
 

SAN DIEGO, CA--(Marketwire - December 8, 2008) - Cypress Bioscience, Inc. (NASDAQ: [ CYPB ]) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will participate in two panel discussions at the RBC Capital Markets Healthcare Conference on December 10, 2008.

The RBC conference is being held at the Westin Times Square in New York, NY. The first panel presentation in which Ms. Johnson will participate, titled 'Reinventing the CNS Therapeutics Armamentarium,' is scheduled for Wednesday, December 10th at 8:00 a.m. Eastern Time. The audio broadcast of this panel presentation can be accessed at [ http://www.wsw.com/webcast/rbc95/panel1/ ].

The second panel presentation in which Ms. Johnson will participate, titled 'New Drugs and Targets for Inflammation and Rheumatology,' is scheduled for Wednesday, December 10th at 10:00 a.m. Eastern Time. The audio broadcast of this panel presentation can be accessed at [ http://www.wsw.com/webcast/rbc95/panel4/ ].

A replay of the presentations will be available at the same web addresses as well as on Cypress' website, [ http://www.cypressbio.com/news/events.php ].

About Cypress Bioscience, Inc.

Cypress Bioscience, Inc. is developing therapeutics and personalized medicine services to facilitate improved and individualized patient care. Cypress' goal is to address the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. We intend to use this approach to improve patient care and create a unique partnership with physicians.

For more information about Cypress, please visit the Company's website at [ www.cypressbio.com ].